UTEC - The University of Tokyo Edge Capital Partners

What UTEC - The University of Tokyo Edge Capital Partners does

UTEC (株式会社東京大学エッジキャピタルパートナーズ / The University of Tokyo Edge Capital Partners Co., Ltd.) is a Tokyo-based, university-affiliated venture capital firm founded in April 2004 by Tomotaka Goji, the drafter of Japan's 1998 Limited Partnership Act for Investment. The firm operates six sequential flagship funds — UTEC1 (2004) through UTEC6 (2025) — representing approximately ¥130 billion (~US$1B) in cumulative LP commitments, plus the AI-focused Deep30 sub-fund. UTEC invests primarily at seed and early stage in science- and technology-driven startups sourced from the University of Tokyo ecosystem, partner research institutions, and an expanding global network.

Its core products are the fund vehicles and the layered value-add modules that surround them: the UTEC Founders Program (Equity Track up to ¥100M and Grant Track up to ¥10M non-dilutive), the Startup Opportunity Club (SOC) executive talent network (100+ placements), the UTEC EIR incubation program, cross-border programs AUGMENT (with Amadeus Capital Partners, UK) and BUDHA (with Blume Ventures, India), an ARCH Venture Partners alliance (US), and ecosystem assets including the 'UTEC Letter' newsletter, 'Tech Startup's Stage Back' podcast, University of Tokyo graduate course, UTEC Tokyo University Scholarship, and the March 2026 Nikkei BP publication 'Science & Technology Area Entrepreneurship Strategy.'

The business model is conventional VC economics: annual management fees on committed/invested capital across the six funds, plus carried interest on successful exits. Customers are two-sided — (i) institutional LPs committing capital to UTEC's funds and (ii) portfolio founders receiving capital plus hands-on operational support (HR, expert mentoring, IP, global expansion, board representation). Track record since 2004 includes 150+ portfolio companies, 20 IPOs and 22 M&A exits (e.g., PeptiDream, Finatext, Microwave Chemical, OriCiro Genomics sold to Moderna), and a 2025 Nobel Prize recognition for portfolio-company founder Professor Shimon Sakaguchi (RegCell).

Name

UTEC - The University of Tokyo Edge Capital Partners

Legal name

株式会社東京大学エッジキャピタルパートナーズ (The University of Tokyo Edge Capital Partners Co., Ltd.)

Website

https://ut-ec.co.jp

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

UTEC is a Tokyo-based, university-affiliated early-stage venture capital firm founded in 2004 that manages six science/technology funds (~¥130B / ~US$1B AUM) investing from seed through IPO in deep-tech startups sourced from the University of Tokyo ecosystem and global research networks.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Securities and Commodity Exchanges (5232), Portfolio Management and Investment Advice (523940)

SIC

Finance Services (6199), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Investment Management Advisory (RIA) (FSAEAAAB)

akta.pro secondary industry

Digital Assets / Crypto Fund of Funds (FSAHAKAL)

Keywords

• Venture capital services
• Deep tech investment
• Seed stage funding
• University startup investing
• Startup incubation programs

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Fund management fees and carried interest: UTEC operates six venture capital funds (UTEC1 through UTEC6) with cumulative commitments of approximately ¥130 billion raised from institutional investors (LPs). Revenue is generated through conventional VC economics: annual management fees on committed/invested capital plus carried interest on successful exits via IPOs and M&A.

Go-to-market motion3 records

Core offering

UTEC is a Japan-based venture capital firm that manages six successive deep-tech/science and technology focused funds (UTEC1 through UTEC6), cumulatively committing approximately JPY 130 billion (~USD 1 billion) from institutional investors. The firm invests primarily at the seed and early stages in startups originating from the University of Tokyo and partner research institutions, providing hands-on support across strategy, HR/talent, expert mentoring, IP, and cross-border expansion through to IPO and M&A exits.

Product overview

UTEC (The University of Tokyo Edge Capital Partners) is a Japan-based venture capital firm that operates as a fund-and-programs platform rather than a unified software product. The platform architecture centers on six sequential venture capital funds — UTEC1 (2004 vintage), UTEC2 (2009), UTEC3 (2013), UTEC4 (2018), UTEC5 (2021), and UTEC6 (2025) — together representing approximately JPY 130 billion (~USD 1 billion) in cumulative commitments across 159 portfolio companies. Layered on top of the funds are several program modules: the UTEC Founders Program (UFP) with its Equity Track and Grant Track sub-modules for rapid seed-stage decisions; the UTEC EIR (Entrepreneur in Residence) incubation program that supports pre-company founders; the Startup Opportunity Club (SOC) talent network for executive matching; cross-border partnership programs AUGMENT (with Amadeus Capital Partners) and BUDHA (with Blume Ventures) for Japan–UK and Japan–India market expansion; the UTEC Letter email newsletter; the 'Tech Startupの舞台裏' (Tech Startup's Stage Back) podcast on Spotify/Apple/Amazon/YouTube; an annual Short Internship program and a Summer Internship for MBA/Ph.D. students; the UTEC Tokyo University Scholarship endowment; a University of Tokyo graduate course titled 'Science & Technology Entrepreneurship' taught by CEO Tomotaka Goji; and the published book 'サイエンス・テクノロジー領域の起業戦略' (Science & Technology Area Entrepreneurship Strategy, March 2026, Nikkei BP). Together the fund vehicles are the core 'product' and the surrounding programs, publications, courses, and talent services form the value-add modules that distinguish UTEC's hands-on support model.

Differentiator

Problem solved

Functional benefit

Brands

• UTEC Founders Program (UFP): Open-application commercialization support program with two tracks: Equity Track (up to JPY 100M investment in seed-stage startups) and Grant Track (up to JPY 10M non-dilutive commercialization support for pre-/post-incorporation teams). Launched May 17, 2021 alongside the UTEC5 fund.
• Deep30投資事業有限責任組合 (Deep30 Investment Limited Partnership)
• UTEC EIR (Entrepreneur in Residence)
• UTEC Letter

Quantifiable outcome

• Cumulative ~¥130 billion raised across 6 funds (as of 2025)
• +3 more outcomes

Named customers1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eight partnerships are on record, tiered flagship and mid-tier.

• Amadeus Capital Partners (UK)flagshipStrategic or Co-development PartnerJoint program 'AUGMENT — Amadeus UTEC Global Market Expansion of Novel Technologies partnership' for cross-border co-investment and value creation between UK/European and Japanese deep-tech startups. UTEC's portfolio company Charco Neurotech was the first joint investment under AUGMENT. UTEC also supports joint sourcing from Cambridge, Oxford, and other UK/European universities.
• ARCH Venture Partners (US)flagshipStrategic or Co-development PartnerGlobal strategic alliance with US-based ARCH Venture Partners for co-investment in deep-tech startups; provides UTEC's US portfolio companies with access to US networks and supports cross-border deal flow.
• Blume Ventures (India)flagshipStrategic or Co-development PartnerJoint program 'BUDHA (Blume UTEC Deep-tech Accelerator)' to support Indian deep-tech startups targeting global markets. UTEC is Blume's largest Japanese LP. UTEC's portfolio company PM Labs (AGARA) was a co-investment under BUDHA. Kiran Mysore (UTEC Principal) sits on Blume's board.
• Oxford Quantum Circuits (OQC)flagshipStrategic or Co-development PartnerUTEC portfolio company (superconducting quantum computing, spun out of University of Oxford); UTEC supported from Series A through Series C (£260M), connected OQC with Japanese academia, and supported APAC market entry.
• University of Tokyo (東京大学)flagshipStrategic or Co-development PartnerFounding institutional partner; UTEC is physically headquartered in the University of Tokyo's South Research Building. Deep collaboration includes joint courses taught by UTEC's CEO, scholarship programs, faculty-led sourcing of portfolio companies, and leveraging Tokyo University research across multiple programs.
• Japan Science and Technology Agency (JST)mid-tierStrategic or Co-development PartnerUTEC collaborates with JST's SCORE and START programs to support university-originated startups; UTEC's CEO Tomotaka Goji drafted Japan's SBIR (1999) framework at MITI/METI.
• Japan Agency for Medical Research and Development (AMED)mid-tierStrategic or Co-development PartnerThrough the 'Drug Discovery Venture Ecosystem Strengthening Program', AMED provided R&D support to UTEC portfolio company RegCell; UTEC supported RegCell's organizational development and global expansion alongside this program.
• Japan Venture Capital Association (JVCA)mid-tierStrategic or Co-development PartnerUTEC CEO Tomotaka Goji serves as Chairman of the Japan Venture Capital Association, the industry's leading industry body. UTEC's COO Noriaki Sakamoto serves as General Manager of the JVCA Planning Department.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• ARCH Venture Partners: US-based early-stage deep-tech VC that is a formal strategic alliance partner of UTEC for cross-border co-investment. Both firms focus on science/technology seed and early-stage investing with university-sourced pipelines, active board representation, and hands-on value-add — the most directly comparable peer on investment philosophy and stage.
• Amadeus Capital Partners: UK/Europe-based deep-tech VC with which UTEC operates the AUGMENT cross-border partnership program. Both firms invest at seed/early stage in science/technology companies sourced from top research universities (Cambridge, Oxford, Tokyo) — making Amadeus the most direct European counterpart to UTEC.
• Blume Ventures: India-based early-stage VC with which UTEC operates the BUDHA (Blume UTEC Deep-tech Accelerator) program; UTEC is Blume's largest Japanese LP. Both firms share an early-stage deep-tech thesis and cross-border co-investment model targeting global markets — making Blume a structural peer despite geographic focus.
• AN Venture Partners: Japan-based VC that co-invests alongside UTEC (e.g., Pahr Therapeutics $14M seed). Specializes in early-stage Japanese deep-tech and life sciences, sharing UTEC's university-sourcing approach and institutional LP base — a closely comparable Japanese peer.

Broad incumbents

• JAFCO Group: Japan's largest venture capital firm by AUM (TSE-listed). Operates across all stages and sectors with broader sector mandate than UTEC's deep-tech specialization. Comparable as a Japan-headquartered institutional VC, but significantly larger and more diversified than UTEC's deep-tech-only focus.
• SBI Investment: Japan-based VC arm of SBI Holdings and one of the largest VC firms in Asia. While much broader than UTEC's deep-tech focus, SBI Investment is a relevant Japan-domiciled incumbent competing for institutional LP capital and large deal flow.
• Globis Capital Partners: Japan-based VC investing across technology sectors with comparable AUM scale to UTEC. Less deep-tech specialized but operates in overlapping Japan seed/early-stage deal flow with a similar institutional LP base.
• Mitsubishi UFJ Capital: Japan-based VC affiliate of Mitsubishi UFJ Financial Group, one of Japan's largest corporate-affiliated VCs. Has co-invested alongside UTEC (e.g., TriOrb Series B) and represents a comparable institutional Japan-domestic VC with broader sector exposure.

Regional players

• DCM Ventures: US-headquartered VC with significant Japan operations and early-stage technology focus. While geographically US-anchored, DCM's Japanese activity and stage focus make it a relevant regional peer for cross-border Japan deep-tech deal flow alongside UTEC.
• World Innovation Lab (WiL): Japan/US dual-headquartered VC investing in early-to-growth stage technology companies. Comparable to UTEC as a Japan-rooted, cross-border tech VC with institutional LP backing, though stage and sector focus are broader than UTEC's deep-tech specialization.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/UTEC_official
• YouTubeyoutube.com/playlist?list=PLZmz1C1JEpj6CizzwT0LTZlVNCRfiTQf_
• Facebookfacebook.com/utecvc
• LinkedInlinkedin.com/company/utec

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments219 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UTEC - The University of Tokyo Edge Capital Partners